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ABSTRACT 
 
Sexuality consists of three aspects that are interrelated and inseparable, biological, physiological and social. The 
biological aspect considers the individual’s capability to give and to receive pleasure. In consequence, it covers the 
functionality of the sexual organs and the physiology of human sexual response cycle. Diagnostic imaging 
modalities, such as single photon emission computed tomography (SPECT) and positron emission tomography 
(PET) have been used to evaluate clinical disorders of the male reproductive system. PET and SPECT procedures 
basically involve the administration of a radiopharmaceutical that has a higher uptake in a specific tumor or tissue. 
The aim of this brief review is to present some radiopharmaceuticals that have been used in the clinical evaluation 
of the male sexual organs (testes, prostate, seminal vesicles, penis) related with male sexuality. This information 
could be useful in better understanding the male sexual response cycle, as well as the sexual disorders, when 
considering the male sexual organs and the pelvic floor. Moreover, the findings obtained with PET and SPECT 
imaging could help to evaluate the efficacy of clinical results of therapeutic procedures. In conclusion, the 
knowledge from these images could aid in better understanding the physiology of the different organs related with 
sexuality. Furthermore, they could be important tools to evaluate the physiological integrity of the involved organs, 
to improve clinical strategies and to accompany the patients under treatment. 
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INTRODUCTION 
 
Sexual activity and the male sexual organs 
Sexuality and its expression contribute to some of 
the most important aspects of human behavior and 
is a powerful, complex bio-psycho-social process 
(Miyagawa et al., 2007; Srivastava et al., 2008). 
Furthermore, sexuality is considered as a personal 
and human dimension that comprises not only 
genitality, but extends beyond the limits of the 
genital impulse. It is characterized as a profound 
and all-inclusive aspect of human personality, 
present from the conception until death, including 
everything that we are and what we do (Melo et 
al., 2006, Miyagawa et al., 2007).  
Sexuality consists of three interrelated and 
inseparable aspects: biological, physiological and 
social. The biological aspect considers the 
individual’s capability to give and receive 
pleasure. In consequence, it covers the 
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functionality of the sexual organs and the 
physiology of human sexual response cycle that 
comprises desire, excitation, orgasm and 
resolution (Masters and Johnson, 1970; Kolodny et 
al., 1979; Dennerstein et al., 2005; Melo et al., 
2006).  
The human male psychosexual cycle is 
categorized into four phases according to 
penodynamic changes: (i) excitement into latency 
and tumescence, (ii) plateau into erection and 
rigidity, (iii) orgasm into emission and ejaculation, 
and (iv) resolution into detumescence and 
refractoriness. During each phase, the specific 
response in neural pathway, penile hemodynamics, 
and functional status occurs. Ejaculation 
represents a major component of male sexual 
behavior and, it is typically accompanied by 
orgasmic sensations (Govier et al., 1995).  
Besides the psychosexual reactions, ejaculation is 
also the result of a coordinated action of a healthy 
male reproductive system that encompasses 
several organs such as the testes, prostate, seminal 
vesicles, ejaculatory ducts, urethra (bulbourethral 
glands) and penis, and pelvic floor muscles 
(Govier et al., 1995; Hatzimouratidis and 
Hatzichristou, 2007). Diseases in these anatomic 
structures can result in complications related to 
reproduction, as well as, the cycle of the sexual 
response. Diagnostic imaging modalities, such as 
ultrasound, computed axial tomography (CT), 
magnetic resonance imaging (MRI), single photon 
emission computed tomography (SPECT) and 
positron emission tomography (PET), have been 
used increasingly to evaluate the clinical disorders 
of the male reproductive system (Futterer et al., 
2008).  
 
Nuclear medicine procedures 
One important aspect of nuclear medicine imaging 
is that this type of imaging demonstrates 
physiology rather than anatomy and it is 
considered as a metabolic (functional) image. 
These techniques are valuable in the early 
diagnosis of various diseases (Wen et al., 2007).  
PET and SPECT procedures basically involve the 
administration of a radiopharmaceutical 
(radiobiocomplex) (Bernardo-Filho et al., 2005) 
that is selected for its ability to be localized with 
high uptake in the specific tumor site or target 
tissue. The radiobiocomplexes are molecular and 
cellular structures labeled with a specific 
radionuclide and are applied to patients after 
appropriate quality control. (Perkins, 2007). The 
image is formed by detection of the gamma rays or 
characteristic X-rays (SPECT) or the photonic 
energy emitted due to the annihilation of the 
positron (PET) as indicated in the Table 1. The 
images obtained provide a functional map of the 
whole distribution and uptake of the 
radiobiocomplex (Saha, 2004, Perkins, 2007; Fanti 
et al, 2007).  
 
 
Table 1- General basis of the SPECT and PET imaging(*). 
Technique Basis 
SPECT 
The gamma rays or characteristic X rays are emitted by the radionuclide that is fixed in the 
radiobiocomplex. These rays are detected by a gamma camera and an image of the localized 
radioactivity is produced. In SPECT, the gamma camera rotates around the body of the patient 
and the image is reconstructed to produce image slices similar to a CT scan. 
PET 
A pair of photonic energy (0.511 MeV) is produced due to the annihilation of the positron 
(antiparticle) in the presence of an electron. PET scanning uses a positron emitting tracer fixed in 
the radiobiocomplex. The pair of photonic energy is detected by the PET scanner, recorded and 
tomographic images of the tracer distribution in the body are reconstructed using mathematical 
algorithms in a computer. 
(*) adaptated from Perkins and Frier, 1999 and Perkins, 2007 
 
 
An ideal PET or SPECT tracer for imaging 
prostate cancer (PC) would (i) identify both local 
and distant lesions, (ii) exhibit high target to non-
target uptake ratios, (iii) be easily available, (iv) be 
formulated by rapid and simple radiochemical 
syntheses, (v) be labeled with a radionuclide with 
favorable decay characteristics and (vi) have 
physical half-life of sufficient duration to allow to 
perform the clinical examination (Saha, 2004, Jana 
and Blaufox, 2006, Fanti et al, 2007). 
SPECT uses the conventional radiobiocomplexes 
and a gamma camera is designed to rotate around 
the body of the patient (see Table 1). The name 
signifies that, at any instant in time, a single 
gamma photon (gamma emitter) or characteristic 
X rays (K capture decay) is being detected. The 
Nuclear Medicine Procedures for the Evaluation of Male Sexual Organs 
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data are reconstructed to form cross-sectional 
images in the same way as with X ray CT 
scanning. SPECT images may be recorded 
following conventional planar imaging without 
increasing the amount of radioactivity 
administered to the patient (Perkins, 2007). Table 
2 shows the main radionuclides used to label 
radiopharmaceuticals used in the SPECT with 
their characteristics, such as decay, main photonic 
energy and physical half-life. 
A particularly sensitive form of imaging known as 
PET scanning uses a positron emitting tracer fixed 
in the radiobiocomplex that is injected into the 
patient (Perkins and Frier, 1999; Perkins, 2007). 
 
 
Table 2 - Main radionuclides used to label radiopharmaceuticals in SPECT. 
Radionuclide Decay Main photon 
energy (keV) 
Physical 
half-life 
Technetium-99m (99mTc) Gamma 140 6 hours 
Indium-111 (111In) Gamma 173 and 247 2.9 days 
Iodine-123 (123I) K capture 160 13 hours 
Iodine 131 (131I) Beta minus and gamma 360 8 days 
Thalium-201 (201Tl) K capture 78 73.1 hours 
(*) adapted from Perkins and Frier, 1999 and Perkins, 2007 
 
 
PET has undergone explosive growth and 
demonstrated great potential for imaging many 
primary and metastatic cancers when compared 
with SPECT. Positron emitting radionuclides are 
produced in a cyclotron optimized for routine 
clinical use and they have a relatively short half-
life (Table 3) (Saha, 2004; Jana and Blaufox, 
2006; Perkins, 2007). 
PET images are a volumetric set of data that can 
be displayed as tomographic images in the 
transaxial, coronal, or sagital planes. A limitation 
of PET is the lack of an anatomical reference 
frame whereas CT is an excellent morphological 
imaging modality with anatomical resolution. The 
combined PET/CT device offers optimal fusion of 
images, allowing the localization of functional 
findings detected by PET in morphological 
structures shown by CT during imaging (Perkins, 
2007). 
 
Table 3 - Half-live of radionuclide positron emitters used to PET scan (*). 
Radionuclide Physical half-life 
Fluorine-18 (18F) 110 minutes 
Carbon-11 (11C) 20 minutes 
Nitrogen-13 (13N) 10 minutes 
Oxygen-15 (15O) 122 seconds 
(*) adapted from Perkins and Frier, 1999, Perkins, 2007; Bouchelouche and Oehr, 2008 
 
 
The aim of this brief review is to present some 
radiobiocomplexes that have been used in the 
clinical evaluation of male sexual organs (mainly 
testes, prostate and penis) related with male 
sexuality. This information could be valuable in 
better understanding the male sexual response 
cycle, as well as the sexual disorders, when 
considering the male sexual organs and the pelvic 
floor. Moreover, the findings obtained with PET 
and SPECT could complement the clinical results 
of therapeutic interventions. 
 
Radiopharmaceuticals used in the clinical 
evaluation of the testes 
Around the time of birth, and occasionally during 
the first weeks thereafter, the testes descend from 
the abdominal space to the scrotum through the 
processes vaginalis. Each hemiscrotum contains a 
testicle (ovoid form) measuring 3 to 5 cm in length 
and 2 to 3 cm in transverse and anteroposterior 
dimensions, and it is enveloped by a dense white 
fibrous capsule, the tunica albuginea (Jana and 
Blaufox, 2006; Futterer et al., 2008). The spectrum 
of conditions that affect the scrotum and its 
contents ranges from incidental findings and 
congenital anomalies to pathologic events that 
Bernardo-Filho, M. et al. 
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require rapid diagnosis and immediate treatment. 
Imaging of the scrotum (testes) is indicated when 
there is an acute situation with pain and swelling 
(Futterer et al., 2008). During sexual intercourse 
the scrotum exhibits characteristic modifications 
(Masters and Johnson, 1970; Kolodny et al., 
1979). 
Nuclear medicine studies have been used to 
evaluate the acute scrotum (testicular torsion 
versus epididymoorchitis) and testicular tumors 
(initial staging of cancer, recurrent/residual disease 
and monitor the treatment response) ((Jana and 
Blaufox, 2006; Futterer et al., 2008). 
The radiopharmaceuticals used in the clinical 
evaluations of disorders of the testes are shown in 
Table 4. 
 
Radiopharmaceuticals used in the clinical 
evaluation of the prostate 
The prostate is a small gland with the size and 
shape of a large chestnut; it surrounds the first 
1.25 inch of the male urethra, proximal to the 
sphincter of the bladder (Jana and Blaufox, 2006). 
Imaging procedures can be valuable in aiding the 
clinical evaluation of the prostate. Furthermore, 
the images of the prostate are highly relevant 
because of its involvement in many male 
disorders. 
 
Table 4 - Radiopharmaceuticals used in the clinical evaluations of the testes. 
Radiopharmaceutical Nuclear 
medicine procedure 
Clinical use Reference 
99mTc-pertechnetate SPECT 
To differentiate acute testicular torsion 
versus from epididymoorchitis 
Kim et al, 1993 
Jana and Blaufox, 
2006 
Gallium-67 citrate SPECT 
To evaluate testicular cancer and to 
stage lymph node metastases  
Willan et al,  
1987,  
Warren, 1995 
18F-FDG PET 
To detect initial staging of cancer, 
recurrent/residual disease and to 
monitor treatment response in 
testicular cancers. 
Ganjoo et al,  
1999 
 
 
However, a number of problems have prevented 
success in its exploration, such as the size and 
location of the prostate. The small size and 
location deep within the pelvis interferes with the 
accurate detection of diseases with noninvasive 
imaging, particularly at the early stages. The other 
problem for nuclear medicine imaging of the 
prostate is the proximity of the urinary bladder. 
Most radiopharmaceuticals are primarily excreted 
by the kidneys, resulting in bladder activity that 
obscures the prostate (Jana and Blaufox, 2006, 
Futterer et al., 2008). 
The prostate changes and commonly enlarges with 
age. The most frequent types of prostate diseases 
are prostatitis, benign prostatic hyperplasia (BPH), 
and PC. PC is the most common malignancy in 
men in several countries (Jemal et al.., 2007). 
Table 5 shows radiopharmaceuticals used in the 
clinical evaluations of disorders of the prostate. 
 
Radiopharmaceuticals used in the clinical 
evaluation of the seminal vesicles, urethra, 
penis and pelvic floor muscles 
The two seminal vesicles (SV) resemble small, 
bulbous pouches and are located just above the 
prostate. SV are directly connected to the vas 
deferens, which transports sperm to them before 
ejaculation. SV make up the bulk of the 
ejaculatory fluid. After adding fluid to the sperm, 
the liquid is transported to the prostate gland. 
Removal of the SV during PC treatment, along 
with the prostate gland in radical prostatectomy, 
can cause dry orgasm. SV cyst, tuberculous 
vesiculitis, adenocarcinoma of the SV, 
neurilemmoma of the SV, phyllodes tumor of the 
prostate, and rhabdomyosarcoma of the SV are 
some diseases related to the SV (Kumar et al, 
2005, Futterer et al., 2008). 
The penis is the male genital organ which carries 
the duct, the urethra, for the emission of sperm and 
ejection of urine. The penis can be affected by 
congenital anomalies, inflammations, and tumors 
(both benign and malignant). The urethra is a 
membranous canal which leads from the bladder to 
the outside of the body and the penis is associated 
with it. Inflammations, tumors and tumor-like 
Nuclear Medicine Procedures for the Evaluation of Male Sexual Organs 
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lesions are found in the urethra (Kumar et al, 
2005).  
The pelvic floor (PF) muscles are associated with 
various organs and are the support of the pelvic 
organs. Pelvic inflammatory disease can be found 
in the PF and is characterized by pelvic pain. Like 
all other organs in the chest or abdominal cavities, 
pelvic organs are not suspended by specialized 
ligaments such as those in the skeletomuscular 
system. In spite of this, the organs of the pelvis 
remain well suspended within their cavity even 
during evacuation. The support system for these 
organs consists of inconspicuous smooth muscle 
elements scattered throughout pelvic structural fat 
tissues and facial structures, in particular 
Denonvilliers' fascia (Stelzner et al., 2005). 
Table 6 shows some radiopharmaceuticals used in 
the clinical evaluations of disorders associated 
with SV, penis and PF muscles. 
 
 
Table 5 - Radiopharmaceuticals used in the clinical evaluations of the prostate. 
Radiopharmaceutical Nuclear medicine 
procedure 
Clinical use Reference 
99mTc-colloid 
SPECT 
To perform lymphoscintigraphy and to 
assess the laterality of lymphatic 
drainage of the prostate, before total 
prostatectomy with pelvic node 
resection 
Zuckier et al, 1990, 
Jana and Blaufox, 
2006 
99TcMDP SPECT To evaluate bone metastases Gerber and Chodak, 1991 
111In-prostascint (murine 
monoclonal antibody) SPECT 
To evaluate nodal recurrence when 
bone scan is negative 
Lange , 2001 
18F-FDG PET It is not very useful. Jana and Blaufox, 2006, Fanti et al, 2007  
11C-Acetate(*) 
PET 
To evaluate local disease, nodal 
metastases and distant metastases due 
to the low urinary excretion.  
Kotzerke et al, 2002 
18F-Acetate (**) PET Limited clinical data Jana and Blaufox, 2006 
11C-Choline(*) 
PET 
To evaluate local disease, nodal 
metastases and distant metastases due 
to the low urinary excretion.  
Kotzerke et al, 2000  
Roivainen et al, 2000 
18F-Choline (***) PET To evaluate local disease, nodal  
metastases and distant metastases. 
Jana and Blaufox,  
2006 
11C-Methionine (*, **) PET It would be useful for evaluating  
recurrent disease.  
Toth et al, 2007 
18F-Fluoride bone  
Scan PET 
Slightly more accurate than  
99mTc-MDP bone particularly with 
CT in a PET/CT scanner, however, not c
effective 
Jana and Blaufox,  
2006 
18F-Fluoro- 
dihydrotestoterone (**) PET 
To monitor treatment response and 
possibility with 18F-FDG to 
Evaluate the androgen insensitivity 
J a andd Blaufox,  
2006 
99mTc-ciprofloxacin SPECT It would be useful to evaluate 
 Chronic bacterial prostatitis. 
Ryu et al, 2003 
(*) The major obstacle for routine used of the radiopharmaceutical labeled with 11C is its short half-life (20 min), (**) Limited 
clinical data, (***) Better than 18F-FDG, less urinary excretion and longer half-life of 18F compared to 11C. 
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Table 6 - Radiopharmaceuticals used in the clinical evaluations of the seminal vesicles, urethra, penis and pelvic 
floor muscles. 
Radiopharmaceutical Nuclear medicine 
procedure 
Anatomic 
Structure 
Clinical use Reference 
99mTc ciprofloxacin SPECT Seminal vesicles seminal vesiculitis Choe et al, 2003 
99mTc-sulphur 
colloid 
SPECT Seminal vesicle Evaluation of partial and 
complete ejaculatory  
obstruction 
Orphan et al, 2008 
18F-FDG PET Penis penile cancer Halac et al, 2007 
99mTc- nanocolloid SPECT Penis sentinel node (SN)  
identification SN 
in carcinoma of the penis 
Valdés Olmos 
et al, 2001 
99mTc-labeled Red 
Blood Cells 
 
SPECT Penis method for the  
objective differentiation  
among psychogenic, 
arteriogenic, and 
venogenic impotence. 
Shen and Kao, 
1998 
Blood pool labeled 
with 99mTc 
SPECT Penis screening test for  
vasculogenic impotence 
Timmermans,  
1998 
18F-FDG PET muscle activity 
in the pelvis 
Studies to identify 
spontaneous muscle 
activity in the pelvis, 
which is strongest at 
Denonvilliers' fascia. 
Stelzner et al,  
2005 
 
 
DISCUSSION 
 
Sexuality is an important component of emotional 
and physical intimacy that men and women 
experience throughout their lives (Camacho and 
Reyes-Ortiz, 2005). The sexual dysfunctions are 
differentiated according to the sexual response 
cycle (Beutel et al., 2006): desire (hypoactive 
sexual desire disorder/sexual aversion), arousal 
(male erectile disorder), orgasm (male orgasmic 
disorder, premature ejaculation). Dyspareunia is 
painful sensations that can occur during or 
following the sexual activity. Sexual deviance 
(paraphilia) includes exhibitionism, fetishism, 
pedophilia, masochism, sadism, and voyeurism. 
Gender identity disorders refer to the conviction of 
living in a body with the wrong gender and the 
wish to adopt the “right” gender (transsexuality). 
Various physiological and clinical conditions 
associated with the human male psychosexual 
cycle have been evaluated with imaging modalities 
(Sumich et al, 2003).  
Nuclear medicine images include SPECT and PET 
and permit the visualization of subtle changes in 
the physiological function in vivo. These findings 
aid the early diagnosis of various diseases (Wen et 
al., 2007). Furthermore, some aspects of sexual 
activity have been studied both with SPECT 
(Tiihonen et al., 1994) and PET (Rauch et al., 
1999; Stoleru et al., 1999; Redoute et al., 2000).  
Concerning the prostate and the testis, a variety of 
radiopharmaceuticals have been used to evaluate 
several clinical disorders and complications 
(Tables 4 and 5) and important findings have 
helped to characterize the diseases as well as the 
consequences of the various possible treatments, 
such as surgery, medications, and physiotherapy. 
An important observation (see Table 4) is that, 
although the 18F-FDG has been widely used in the 
PET scans for various types of cancer, in the case 
of PC, this radiopharmaceutical is not very useful 
(Jana and Blaufox, 2006). 
Considering the SV, penis and PF muscles, the use 
of the nuclear medicine techniques is still limited. 
However, some studies have revealed the 
relevance of these techniques in the clinical 
evaluation of the penis and SV (Halac et al. 2007). 
Choe et al, 2003 have reported the use of the Tc-
99m ciprofloxacin SPECT imaging of a patient 
with prostatitis syndrome, in whom seminal 
vesiculitis was finally diagnosed.  Orhan et al. 
(2008) have defined a novel technique in the 
diagnosis of partial and complete ejaculatory duct 
obstruction (EDO). Men with suspected EDO were 
initially evaluated by transrectal ultrasound 
(TRUS). Subsequently, all patients underwent 
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TRUS-guided SV scintigraphy. 99mTc sulphur 
colloid solution was injected into each SV under 
TRUS guidance and patients were immediately 
investigated by scintigraphy. After patients 
ejaculated, scintigraphy was repeated. The 
difference between the two measurements with 
respect to the technetium-99m count was used to 
measure the percentage of emptying. The authors 
concluded that SV scintigraphy is unique in that it 
incorporates the physiologic aspect of ejaculation 
into a diagnostic intervention, which the authors 
believe is especially important in the diagnosis of 
functional EDO.  
Halac et al. (2007) have demonstrated, in patients 
with penile cancer, the relevance of the 18F-FDG 
PET for identifying metastatic lesions and for 
therapeutic strategy planning. Moreover, Ravizzini 
et al. (2001) have reported early on the importance 
of the 18F-FDG in the detection of metastatic 
penile squamous cell carcinoma. Valdés Olmos et 
al. (2001) have evaluated the findings of 
lymphoscintigraphy for sentinel node (SN) 
identification in penile carcinoma. It is concluded 
that penile lymphoscintigraphy is a valid and well-
tolerated method for lymphatic mapping and SN 
identification. The SN identification may lead to 
more accurate staging and avoid extensive lymph 
node dissection in the majority of patients with 
penile carcinoma. Shen and Kao (1998) have used 
the 99mTc-labeled RBC erection penogram (Tc-
RBC penogram) coupled with intracavernosal 
injection of prostaglandin to evaluate the penile 
hemodynamic changes during tumescence. They 
conclude that the Tc-RBC penogram is a simple, 
noninvasive, and valuable method for the objective 
differentiation among psychogenic, arteriogenic, 
and venogenic erectile dysfunction. Timmermans, 
1998 reported that the radioisotope erection 
penogram is a noninvasive, reproducible, and 
reliable screening test for the evaluation of 
vasculogenic erectile dysfunction. 
The organs of the male reproductive tract are also 
closely involved with the sexual activity and 
clinical disorders of these organs could also 
contribute to the impairment of the normal 
response of the cycle of sexual activity. Thus, they 
have also been studied using imaging techniques 
based on the use of radiopharmaceuticals (Fanti et 
al., 2007, Futterer et al., 2008).  
In conclusion, the knowledge acquired using 
nuclear medicine imaging of the male reproductive 
tract could aid in better understanding the 
physiology of the different organs related with 
sexuality. Moreover, they are important tools in 
evaluating the physiological integrity of the organs 
involved and improving the clinical strategies for 
patients under treatment with medication and/or 
psycho-sexual and physiotherapeutic strategies. 
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RESUMO 
 
A sexualidade consiste de três aspectos que são 
inter-relacionados e inseparáveis: biólogico, 
fisiológico e social. O aspecto biológico considera 
a capacidade individual de dar e receber prazer. 
Em consequência, envolve a funcionalidade dos 
órgãos sexuais e a fisiologia do ciclo da resposta 
sexual humana. As imagens cintilográficas single 
photon emission computed tomography (SPECT) e 
positron emission tomography (PET) têm sido 
usadas para avaliar comprometimentos clínicos do 
sistema reprodutor masculino. Os procedimentos 
PET e SPECT envolvem a administração de um 
radiofármaco que é selecionado pela sua abilidade 
de ser captado em um específico tumor ou tecido. 
O objetivo dessa pequena revisão é apresentar os 
radiofármacos que têm sido empregados na 
avaliação clínica de órgãos sexuais masculinos 
(testículos, prostáta, vesícula seminal, pênis) 
relacionados com a sexualidade masculina. Essa 
informação poderia ajudar a entender melhor a 
resposta sexual masculina, assim como as 
disfunções associdas com os órgãos sexuais 
masculinos e do assolho pélvico. Mais ainda, os 
achados clínicos obtidos com o PET e SPECT 
poderiam contribuir para avaliar a eficácia dos 
procedimentos terapêuticos. Em conclusão, a 
aplicação das imagens obtidas pelas técnicas da 
medicina nuclear na avaliação dos órgãos do 
sistema reprodutivo masculino poderia contribuir 
para uma melhor compreensão da fisiologia dos 
diferentes órgãos relacionados com a sexualidade. 
Essas imagens poderiam ser importante ferramenta 
na avaliação da fisiologia dos órgãos relacionados, 
para melhorar as estratégicas clínicas e para 
acompanhar os pacientes em tratamento 
medicamentoso ou psico-sexual ou 
fisioterapeutico. 
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